The largest database of trusted experimental protocols

Acquity beh 300 uplc column

Manufactured by Waters Corporation

The Acquity BEH-300 UPLC column is a high-performance liquid chromatography (HPLC) column designed for use with Ultra-Performance Liquid Chromatography (UPLC) systems. The column features a sub-2-micron particle size and a proprietary bonded phase technology to provide efficient separations and high-resolution analysis of a wide range of analytes.

Automatically generated - may contain errors

2 protocols using acquity beh 300 uplc column

1

UPLC-MS Analysis of Protein-Drug Adducts

Check if the same lab product or an alternative is used in the 5 most similar protocols
UPLC-MS analysis was carried out with a Waters Acquity H-Class system utilizing a Waters Acquity BEH-300 UPLC column packed with a C4 stationary phase (2.1 × 50 mm, 1.7 µm) in conjunction with HRMS analysis by a Waters Xevo-G2 quadropole-TOF electrospray mass spectrometer to detect and analyze protein-drug adducts. Each enzyme (2 µM) in 25 mM Tris buffer, pH 8, was incubated in the absence or presence of drug (50 µM) at room temperature for 5 hrs or for 1 hr and 24 hrs to assess stability of the adducts. Trifluoroacetic acid (0.1% final) was used to quench the reactions, samples were filtered through a 0.22 um filter and analyzed using UPLC-MS as follows: Mobile phase: 0–1 min 90% water + 10% ACN + 0.1% formic acid, 1–7.5 min gradient up to 20% water + 80% ACN + 0.1% formic acid, 7.5–8.4 min 20% water + 80% ACN + 0.1% formic acid, 8.4–8.5 min gradient up to 90% water + 10% ACN + 0.1% formic acid, 8.5–10 min 90% water + 10% ACN + 0.1% formic acid. Flow rate = 0.3 mL min−1. T = 60 °C.
+ Open protocol
+ Expand
2

UPLC-MS Analysis of Protein-Drug Adducts

Check if the same lab product or an alternative is used in the 5 most similar protocols
UPLC-MS analysis was carried out with a Waters Acquity H-Class system utilizing a Waters Acquity BEH-300 UPLC column packed with a C4 stationary phase (2.1 × 50 mm, 1.7 µm) in conjunction with HRMS analysis by a Waters Xevo-G2 quadropole-TOF electrospray mass spectrometer to detect and analyze protein-drug adducts. Each enzyme (2 µM) in 25 mM Tris buffer, pH 8, was incubated in the absence or presence of drug (50 µM) at room temperature for 5 hrs or for 1 hr and 24 hrs to assess stability of the adducts. Trifluoroacetic acid (0.1% final) was used to quench the reactions, samples were filtered through a 0.22 um filter and analyzed using UPLC-MS as follows: Mobile phase: 0–1 min 90% water + 10% ACN + 0.1% formic acid, 1–7.5 min gradient up to 20% water + 80% ACN + 0.1% formic acid, 7.5–8.4 min 20% water + 80% ACN + 0.1% formic acid, 8.4–8.5 min gradient up to 90% water + 10% ACN + 0.1% formic acid, 8.5–10 min 90% water + 10% ACN + 0.1% formic acid. Flow rate = 0.3 mL min−1. T = 60 °C.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!